GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fermenta Biotech Ltd (BOM:506414) » Definitions » Short Percentage of Float

Fermenta Biotech (BOM:506414) Short Percentage of Float


View and export this data going back to 2000. Start your Free Trial

What is Fermenta Biotech Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Fermenta Biotech's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Fermenta Biotech's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fermenta Biotech's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fermenta Biotech's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Fermenta Biotech's Short Percentage of Float falls into.


;
;

Fermenta Biotech Business Description

Traded in Other Exchanges
N/A
Address
Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments that are Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.

Fermenta Biotech Headlines

No Headlines